Crossmark

Efficacy and safety of polyethylene glycol loxenatide in type 2 diabetic patients: a systematic review and meta-analysis of randomized controlled trials

Crossref DOI link: https://doi.org/10.1038/s41598-023-46274-x

Published Online: 2023-11-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Salamah, Hazem Mohamed

Marey, Ahmed

Elsayed, Esraa

Hasan, Mohammed Tarek

Mahmoud, Abdelrahman

Abualkhair, Khaled Alsayed

Abo-elnour, Dina Essam

Abdelhaleem, Ibrahim Abdelmonaem

Abd-Elgawad, Mohamed
Funding

Funding for this research was provided by:

The Science, Technology & Innovation Funding Authority
License Information

Text and Data Mining valid from 2023-11-03

Version of Record valid from 2023-11-03
More Information

Article History

Received: 14 May 2023

Accepted: 30 October 2023

First Online: 3 November 2023

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below